
<!DOCTYPE html>
<html lang="en-US" class=" js">
<head>
<!-- Google tag (gtag.js) -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-1CD9F90731"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-1CD9F90731');
</script>


<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-8495225890363177"
     crossorigin="anonymous"></script>
     
 

<link rel="stylesheet" href="https://education-academia.github.io/css/bootstrap.min.css">
<link rel="stylesheet" href="https://education-academia.github.io/css/style.css">
<link rel="stylesheet" href="https://education-academia.github.io/css/custom.css">
<link rel="icon" href="https://education-academia.github.io/images/favicon.png" type="image/x-icon">
<link href="https://cdn.rawgit.com/westonganger/bootstrap-directional-buttons/master/dist/bootstrap-directional-buttons.css" rel="stylesheet" type="text/css">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>USFDA approved Sun Pharma for the manufacture of INFUGEM. This INFUGEM is used to treat
</title>
<meta name="description" content="INFUGEM is indicated in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer.INFUGEM is a trademark of Sun Pharma Global FZE.The US FDAs warning letter said that Sun Pharma had failed to use suitable equipment in manufacturing drug products. It is your responsibility to ensure that only appropriately designed and maintained equipment are used in the manufacture of your drug products, the drug regulator said.Glen Saldanha, said his company has been pursuing drug discovery for two decades. We brought an innovative SGLT-2 inhibitor called Remogliflozin for treating diabetes to India, and developed 5-6 drugs both biologics and small molecules, Saldanha said.There are other category defining brands such as Coldact & Flustat (cold & flu), Brustan, Painamol & Paduden (analgesics), Aspenter, Aspacardin, Nudrate & Fortifikat (lifestyle OTCs), Gestid (digestives) and Chericof (cough).">
<meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1'>
<meta name="keywords" content=" Who is the manufacturer of Infugem?, What is the FDA warning letter Sun Pharma?, What is the new drug discovery of Sun Pharma?, What are the major products of Sun Pharma?, What is Sun Pharma used for?, How many products are there in Sun Pharma?, What are new to brand prescriptions?, Which are the new technologies in drug discovery?, Which company merged with Sun Pharma? ">
</head>
<body data-rsssl="1" class="page-template-default custom-background custom-background-white custom-font-enabled single-author" style="padding: 0px 0px 154px;">
<div id="page" class="site" style="height: auto !important;">
<header id="masthead" class="site-header" role="banner">
<div class="io-title-description">
<a href="https://education-academia.github.io" title="Change your future" rel="home">EDUCATION FOR ALL
</a>
<br>
<a class="site-description">The MCQ hub
</a>
</div>
<nav id="site-navigation" class="themonic-nav" role="navigation">
<a class="assistive-text" href="#main" title="Skip to content">Skip to content
</a>
<ul id="menu-top" class="nav-menu">
<li id="menu-item-695195" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-695195">
<a href="https://education-academia.github.io/">Home
</a>
</li>
</ul>
<select class="selectnav" id="selectnav1">
<option value="">Menu
</option>
<option value="https://education-academia.github.io">HOME
</option>
</select>
</nav>
<!-- #site-navigation -->
<div class="clear">
</div>
</header>
<!-- #masthead -->
<div id="main" class="wrapper">
<div id="primary" class="site-content">
<div id="content" role="main">
<article id="post-1014223" class="post-1014223 page type-page status-publish hentry">
<header class="entry-header">
<h1 class="entry-title"> CURRENT AFFAIRS
</h1>
</header>
<div class="entry-content">
<div class="f-l">
<a href="https://education-academia.github.io/current-affairs/2018/which-bank-launches-indias-first-interactive-credit-card-named-nexxt-credit-card.html" class="btn btn-info btn-arrow-left" role="button" aria-pressed="true">Previous
</a>
</div>
<div class="f-r">
<a href="https://education-academia.github.io/current-affairs/2018/who-built-the-khairatabad-masjid-at-hyderabad.html" class="btn btn-info btn-arrow-right" role="button" aria-pressed="true">Next
</a>
</div>
<div style="text-align:center">
<h2>2018 
</h2>
<h3>
</h3>
<p style="text-align: center;">
<a href="https://drive.google.com/drive/folders/1JxfIMvv4AW-4Jl_pC6NHChgZJETuMZiE?usp=share_link" target="_blank" rel="noopener">
<span style="color: #008000;">
<strong>DOWNLOAD FREE PDF BOOK (USEFUL FOR TEACHERS/INSTRUCTORS/COACHING INSTITUTES)
</strong>
</span>
<span style="color: #ff0000;">
<img src="https://education-academia.github.io/download.gif">
</span>
</a>
</p>
</div>
<strong> USFDA approved Sun Pharma for the manufacture of INFUGEM. This INFUGEM is used to treat 
</strong>
<p>(A) Tuberculosis 
</p>
<p>(B) AIDS 
</p>
<p>(C) ** Cancer 
</p>
<p>(D) Ebola 
</p>
<p>
<div style ="text-align:center">
<h3>EXPLANATIONS BELOW
</h3>
</div>
<p>
<strong>Concept note-1:
</strong>-INFUGEM is indicated in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer.
</p>
<p>
<strong>Concept note-2:
</strong>-INFUGEM is a trademark of Sun Pharma Global FZE.
</p>
<p>
<strong>Concept note-3:
</strong>-The US FDA’s warning letter said that Sun Pharma had failed to use suitable equipment in manufacturing drug products. “It is your responsibility to ensure that only appropriately designed and maintained equipment are used in the manufacture of your drug products, ” the drug regulator said.
</p>
<p>
<strong>Concept note-4:
</strong>-Glen Saldanha, said his company has been pursuing drug discovery for two decades. “We brought an innovative SGLT-2 inhibitor called Remogliflozin for treating diabetes to India, and developed 5-6 drugs both biologics and small molecules, ” Saldanha said.
</p>
<p>
<strong>Concept note-5:
</strong>-There are other category defining brands such as Coldact &amp; Flustat (cold &amp; flu), Brustan, Painamol &amp; Paduden (analgesics), Aspenter, Aspacardin, Nudrate &amp; Fortifikat (lifestyle OTCs), Gestid (digestives) and Chericof (cough). 
<div class="f-l">
<a href="https://education-academia.github.io/current-affairs/2018/which-bank-launches-indias-first-interactive-credit-card-named-nexxt-credit-card.html" class="btn btn-info btn-arrow-left" role="button" aria-pressed="true">Previous
</a>
</div>
<div class="f-r">
<a href="https://education-academia.github.io/current-affairs/2018/who-built-the-khairatabad-masjid-at-hyderabad.html" class="btn btn-info btn-arrow-right" role="button" aria-pressed="true">Next
</a>
</div>
<p style="text-align: center;">
<a href="https://play.google.com/store/books/author?id=Narayan+Changder" target="_blank" rel="noopener">
<span style="color: #008000;">
<strong>BUY E-BOOK WITH ANSWER KEYS GIVEN AT THE END OF EVERY PAGE
</strong>
</span>
<span style="color: #ff0000;">
<img src="https://education-academia.github.io/buynow.webp">
</span>
</a>
</p>
</div>
<!-- .entry-content -->
<footer class="entry-meta">
</footer>
<!-- .entry-meta -->
</article>
<!-- #post -->
<div id="comments" class="comments-area">
</div>
<!-- #comments .comments-area -->
</div>
<!-- #content -->
</div>
<!-- #primary -->
<div id="secondary" class="widget-area" role="complementary">
<aside id="search-3" class="widget widget_search">
<ul>
<li>
<a href="https://education-academia.github.io/current-affairs/2016/1.html">
<strong>CURRENT AFFAIRS-2016
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2017/1.html">
<strong>CURRENT AFFAIRS-2017 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2018/1.html">
<strong>CURRENT AFFAIRS-2018 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2019/1.html">
<strong>CURRENT AFFAIRS-2019 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2020/1.html">
<strong>CURRENT AFFAIRS-2020 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2021/1.html">
<strong>CURRENT AFFAIRS-2021 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2022/1.html">
<strong>CURRENT AFFAIRS-2022 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2023/1.html">
<strong>CURRENT AFFAIRS-2023 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2024/1.html">
<strong>CURRENT AFFAIRS-2024 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2025/1.html">
<strong>CURRENT AFFAIRS-2025
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2026/1.html">
<strong>CURRENT AFFAIRS-2026
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2027/1.html">
<strong>CURRENT AFFAIRS-2027
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2028/1.html">
<strong>CURRENT AFFAIRS-2028 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2029/1.html">
<strong>CURRENT AFFAIRS-2029 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2030/1.html">
<strong>CURRENT AFFAIRS-2030 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/miscellaneous/1.html">
<strong>CURRENT AFFAIRS-MISCELLANEOUS 
</strong>
</a>
</li>
</ul>
</aside>
</div>
<!-- #secondary -->
</div>
<!-- #main .wrapper -->
<footer id="colophon" role="contentinfo">
<div class="site-info">
<div class="footercopy">
</div>
<div class="footercredit">
</div>
<div class="clear">
</div>
</div>
<!-- .site-info -->
</footer>
<!-- #colophon -->
<div class="site-wordpress">
</div>
<!-- .site-info -->
<div class="clear">
</div>
</div>
<!-- #page -->
<script src="https://education-academia.github.io/js/jquery.min.js">
</script>
<script src="https://education-academia.github.io/js/bootstrap.min.js">
</script>
</body>
</html>